Quarterly report · Q3

Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 38
MetricValuePeriodScopeSource row
Revenue¥4.5bn2023-06-01 → 2024-02-29StandaloneNet sales
Revenue¥6.3bn2022-06-01 → 2023-05-31StandaloneNet sales (5-year summary)
Revenue¥4.6bn2022-06-01 → 2023-02-28StandaloneNet sales
Operating income¥252m2023-06-01 → 2024-02-29StandaloneOperating income
Operating income¥325m2022-06-01 → 2023-02-28StandaloneOperating income
Ordinary income¥246m2023-06-01 → 2024-02-29StandaloneOrdinary income
Ordinary income¥351m2022-06-01 → 2023-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥309m2022-06-01 → 2023-02-28StandaloneOrdinary income
Profit before tax¥287m2023-06-01 → 2024-02-29StandaloneIncome before income taxes
Profit before tax¥309m2022-06-01 → 2023-02-28StandaloneIncome before income taxes
Net income¥191m2023-06-01 → 2024-02-29StandaloneProfit loss
Net income¥256m2022-06-01 → 2023-05-31StandaloneNet income loss (5-year summary)
Net income¥230m2022-06-01 → 2023-02-28StandaloneProfit loss
Total assets¥5.3bnat 2024-02-29StandaloneAssets
Total assets¥4.9bnat 2023-05-31StandaloneAssets
Total assets¥5.0bnat 2023-02-28StandaloneTotal assets (5-year summary)
Total liabilities¥3.2bnat 2024-02-29StandaloneLiabilities
Total liabilities¥3.0bnat 2023-05-31StandaloneLiabilities
Net assets / equity¥2.1bnat 2024-02-29StandaloneNet assets
Net assets / equity¥1.9bnat 2023-05-31StandaloneNet assets
Net assets / equity¥1.9bnat 2023-02-28StandaloneNet assets (5-year summary)
Cash and deposits¥954mat 2024-02-29StandaloneCash and deposits
Cash and deposits¥853mat 2023-05-31StandaloneCash and deposits
EPS (basic)¥48.22023-06-01 → 2024-02-29StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥24.522023-12-01 → 2024-02-29dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥61.462022-06-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥21.532022-12-01 → 2023-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥47.272023-06-01 → 2024-02-29StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.122022-06-01 → 2023-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥58.552022-06-01 → 2023-02-28StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192022-06-01 → 2023-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio39.9%at 2024-02-29StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio37.5%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2024-02-29StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-02-28StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥1.6bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥1.6bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2024-02-29−¥22m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥563m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥563m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2024-02-29−¥40m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥2.3bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥2.3bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2024-02-29¥314m
—segment totalrevenue2023-06-01 → 2024-02-29¥4.5bn
—segment totalrevenue external2023-06-01 → 2024-02-29¥4.5bn
—segment totalsegment profit2023-06-01 → 2024-02-29¥252m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-02-29¥4.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-02-29¥4.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-02-29¥252m
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥25m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥75m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥426m
—segment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥325m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥325m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember425507000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember-74757000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember-25340000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember325409000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember325409000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember-JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember325409000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember2250660000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember562884000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember1641467000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember4455013000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember4455013000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember-JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember4455013000JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember-JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember-JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember-JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember-JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember-JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember-JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember2250660000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember562884000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember1641467000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember4455013000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember4455013000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember-JPY
Net salesCurrentYTDDuration_NonConsolidatedMember4455013000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember313619000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember-39613000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember-21617000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember252388000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember252388000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember-JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember252388000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)福岡財務支局長
Filing date cover pageFilingDateInstant2024-04-12
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第78期第3四半期(自 2023年12月1日 至 2024年2月29日)
Company name cover pageFilingDateInstant
Original text (Japanese)室町ケミカル株式会社
Company name in english cover pageFilingDateInstantMUROMACHI CHEMICALS INC.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長  青木 淳一
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5
Telephone number address of registered headquarter cover pageFilingDateInstant0944-41-2131
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役 管理本部長  井内 聡
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5
Telephone number nearest place of contact cover pageFilingDateInstant0944-41-2131
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役 管理本部長  井内 聡
Place for public inspection cover page (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2023-05-31pass
balance sheet identitynon_consolidated 2024-02-29pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2024-02-29pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-02-28pass
statement vs summary · revenuenon_consolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2024-02-29pass